SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-24-000016
Filing Date
2024-03-07
Accepted
2024-03-07 08:32:14
Documents
17
Period of Report
2024-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20240306x8k.htm   iXBRL 8-K 76431
2 EX-99.1 alim-20240306xex99_1.htm EX-99.1 228034
3 GRAPHIC alim-20240306xex99_1g001.jpg GRAPHIC 55720
  Complete submission text file 0001267602-24-000016.txt   545172

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20240306.xsd EX-101.SCH 2387
5 EX-101.DEF alim-20240306_def.xml EX-101.DEF 3793
6 EX-101.LAB alim-20240306_lab.xml EX-101.LAB 20916
7 EX-101.PRE alim-20240306_pre.xml EX-101.PRE 15454
18 EXTRACTED XBRL INSTANCE DOCUMENT alim-20240306x8k_htm.xml XML 6591
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 24728252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)